List of Excipients in API nitrofurantoin oral suspension
✉ Email this page to a colleague
Excipients in ANDA-approved (generic) drugs containing nitrofurantoin oral suspension
Detailed excipient profiles for nitrofurantoin oral suspension
Excipient focus: ANHYDROUS CITRIC ACID
nitrofurantoin oral suspension drug variants containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| PAI Holdings LLC dba PAI Pharma | nitrofurantoin oral suspension | 0121-1996 |
| >Company | >Ingredient | >NDC |
nitrofurantoin oral suspension drug variants not containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM
nitrofurantoin oral suspension drug variants containing CARBOXYMETHYLCELLULOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| PAI Holdings LLC dba PAI Pharma | nitrofurantoin oral suspension | 0121-1996 |
| >Company | >Ingredient | >NDC |
nitrofurantoin oral suspension drug variants not containing CARBOXYMETHYLCELLULOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERIN
nitrofurantoin oral suspension drug variants containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| PAI Holdings LLC dba PAI Pharma | nitrofurantoin oral suspension | 0121-1996 |
| >Company | >Ingredient | >NDC |
nitrofurantoin oral suspension drug variants not containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM ALUMINUM SILICATE
nitrofurantoin oral suspension drug variants containing MAGNESIUM ALUMINUM SILICATE
| Company | Ingredient | NDC |
|---|---|---|
| PAI Holdings LLC dba PAI Pharma | nitrofurantoin oral suspension | 0121-1996 |
| >Company | >Ingredient | >NDC |
nitrofurantoin oral suspension drug variants not containing MAGNESIUM ALUMINUM SILICATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN
nitrofurantoin oral suspension drug variants containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| PAI Holdings LLC dba PAI Pharma | nitrofurantoin oral suspension | 0121-1996 |
| >Company | >Ingredient | >NDC |
nitrofurantoin oral suspension drug variants not containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLPARABEN
nitrofurantoin oral suspension drug variants containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| PAI Holdings LLC dba PAI Pharma | nitrofurantoin oral suspension | 0121-1996 |
| >Company | >Ingredient | >NDC |
nitrofurantoin oral suspension drug variants not containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM CITRATE
nitrofurantoin oral suspension drug variants containing SODIUM CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| PAI Holdings LLC dba PAI Pharma | nitrofurantoin oral suspension | 0121-1996 |
| >Company | >Ingredient | >NDC |
nitrofurantoin oral suspension drug variants not containing SODIUM CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SORBITOL
nitrofurantoin oral suspension drug variants containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| PAI Holdings LLC dba PAI Pharma | nitrofurantoin oral suspension | 0121-1996 |
| >Company | >Ingredient | >NDC |
nitrofurantoin oral suspension drug variants not containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SUCRALOSE
nitrofurantoin oral suspension drug variants containing SUCRALOSE
| Company | Ingredient | NDC |
|---|---|---|
| PAI Holdings LLC dba PAI Pharma | nitrofurantoin oral suspension | 0121-1996 |
| >Company | >Ingredient | >NDC |
nitrofurantoin oral suspension drug variants not containing SUCRALOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
nitrofurantoin oral suspension drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| PAI Holdings LLC dba PAI Pharma | nitrofurantoin oral suspension | 0121-1996 |
| >Company | >Ingredient | >NDC |
nitrofurantoin oral suspension drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch